Litcius/Paper detail

Response to neoadjuvant chemotherapy and the 21-gene Breast Recurrence Score test in young women with estrogen receptor-positive early breast cancer

Tal Sella, Shari Gelber, Philip D. Poorvu, Hee-Jeong Kim, Laura S. Dominici, Yaileen D. Guzmán‐Arocho, Laura C. Collins, Kathryn J. Ruddy, Rulla M. Tamimi, Jeffrey Peppercorn, Lidia Schapira, Virginia F. Borges, Steven E. Come, Ellen Warner, Craig Snow, Debbie Jakubowski, Christy Russell, Eric P. Winer, Shoshana M. Rosenberg, Ann H. Partridge

2020Breast Cancer Research and Treatment24 citationsDOI

Topics & Concepts

Breast cancerMedicineInternal medicineEstrogen receptorOncologyChemotherapyCancerLogistic regressionStage (stratigraphy)EstrogenCohortPathologicalProspective cohort studyGynecologyGastroenterologyBiologyPaleontologyBreast Cancer Treatment StudiesBreast Lesions and CarcinomasMedical Imaging Techniques and Applications
Response to neoadjuvant chemotherapy and the 21-gene Breast Recurrence Score test in young women with estrogen receptor-positive early breast cancer | Litcius